Table 4. Baseline characteristics of patient populations prior to data pooling.
Proof-of-concept1 | Utilization study | Pooled dataset | ||||
n = 30 | % | N = 77 | % | n = 107 | % | |
Age, mean±SD | 36±18 | 37±19 | 36±19 | |||
Age, range (years) | 6–67 | 6–72 | 6–72 | |||
Male/female ratio | 1.7 | 1.3 | 1.4 | |||
Nutritional status | ||||||
BMI2 (kg/m) mean±SD | 18.8±3.4 | 18.6±3.6 | 18.6±3.5 | |||
Severe malnutrition (BMI<16.5) | 8 | 26.6 | 18 | 23.4 | 26 | 24.3 |
Diagnostic findings | ||||||
Trypanosomes in blood | 30 | 100.0 | 72 | 93.5 | 102 | 95.3 |
Trypanosomes in CSF3 | 28 | 93.33 | 69 | 89.6 | 97 | 90.7 |
WBC4 count in CSF | 92±57 | 78±64 | 82±62 | |||
Clinical manifestations | ||||||
Headache | 27 | 90.0 | 73 | 94.8 | 100 | 93.5 |
Fever (>37.5) | 7 | 23.3 | 13 | 16.9 | 20 | 18.7 |
Oedema | 6 | 20.0 | 25 | 32.5 | 31 | 29.0 |
Joint pains | 29 | 96.7 | 76 | 98.7 | 105 | 98.1 |
Daytime sleep | 24 | 80.0 | 63 | 81.8 | 87 | 81.3 |
Night time sleep | 23 | 76.7 | 50 | 64.9 | 73 | 68.2 |
Abnormal movements | 8 | 26.7 | 20 | 26.0 | 28 | 26.2 |
Walking difficulties | 13 | 43.3 | 53 | 68.8 | 66 | 61.7 |
Time period of enrolment | Oct 06–May 07 | Oct 07–Aug 08 | Oct 06–Aug 08 |
Note:
no suramin pre-treatment;
body mass index,
cerebrospinal fluid,
white blood cell.